Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
4(17%)
Results Posted
33%(1 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_1
10
43%
Ph not_applicable
6
26%
Ph phase_2
7
30%

Phase Distribution

10

Early Stage

7

Mid Stage

0

Late Stage

Phase Distribution23 total trials
Phase 1Safety & dosage
10(43.5%)
Phase 2Efficacy & side effects
7(30.4%)
N/ANon-phased studies
6(26.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

42.9%

3 of 7 finished

Non-Completion Rate

57.1%

4 ended early

Currently Active

4

trials recruiting

Total Trials

23

all time

Status Distribution
Active(4)
Completed(3)
Terminated(4)
Other(12)

Detailed Status

unknown12
Recruiting4
Withdrawn3
Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
4
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 110 (43.5%)
Phase 27 (30.4%)
N/A6 (26.1%)

Trials by Status

terminated14%
unknown1252%
withdrawn313%
completed313%
recruiting417%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT07547735Phase 2

Phase II Clinical Trial of UC-MSCs in the Treatment of Knee Osteoarthritis

Recruiting
NCT05279768Phase 1

Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.

Completed
NCT04865107Phase 2

Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial

Completed
NCT06407297Not Applicable

UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes

Recruiting
NCT05224960Phase 2

Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

Recruiting
NCT06463847Phase 1

Phase I Clinical Trial of UC-MSCs in the Treatment of Knee Osteoarthritis

Recruiting
NCT05719012Phase 2

Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Long COVID-19

Withdrawn
NCT03059355Phase 1

Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.

Terminated
NCT05507762Phase 1

Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)

Unknown
NCT04490486Phase 1

Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19

Withdrawn
NCT05121870Phase 2

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis

Unknown
NCT04562025Not Applicable

Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy

Unknown
NCT04288102Phase 2

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)

Completed
NCT04269525Phase 2

Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia

Unknown
NCT04273646Not Applicable

Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

Unknown
NCT04339660Phase 1

Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia

Unknown
NCT04293692Not Applicable

Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus

Withdrawn
NCT03798028Not Applicable

The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritis

Unknown
NCT02672306Phase 1

Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease

Unknown
NCT03414697Not Applicable

Transplantation of Umbilical Cord-derived Mesenchymal Stem Cells Via Different Routes

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
23